08/11/2005 (Agence Europe) - The Swiss pharmaceuticals group, Roche, announced on Monday that it would be producing 300 million treatments of Tamiflu annually by the end of 2006, that is, ten times more than in 2004. “Patients' needs in case of a pandemic remain our top priority. We have continuously increased our production capacities”, said Bill Burns, who heads the group's pharmaceutical division. Until now, he has refused to give figures relating to the production of this anti-viral...